US Stock Market Move | New drug Kaitongle has been approved for market in China, and ZAI LAB (ZLAB.US) rose more than 7%.
As of the time of drafting, the stock rose more than 7%, reaching $18.84 per share.
On Wednesday, the stock price of Zai Lab (ZLAB.US) rose, as of the time of writing, the stock rose more than 7%, to $18.84. The stock of Zai Lab in Hong Kong rose 6.24% today. In terms of news, Zai Lab announced that the China National Medical Products Administration has approved the new drug application for Pimozide Quetiapine Capsules (Kaitielle), used to treat adult schizophrenia. This is the first schizophrenia therapy with a completely new mechanism of action to be approved in over 70 years, marking a breakthrough in the treatment of schizophrenia.
Related Articles
US Stock Market Move | Gold and silver mining stocks generally fell, with Hecla Mining Company (HL.US) dropping 3.5%.
US Stock Market Move | YARTEMLEA drug receives FDA approval Omeros Corporation (OMER.US) surges by nearly 65%
US Stock Market Move | The US car safety regulatory agency has launched a defect investigation into the Model 3. Tesla, Inc. (TSLA.US) fell more than 1.4% in the short term.
US Stock Market Move | Gold and silver mining stocks generally fell, with Hecla Mining Company (HL.US) dropping 3.5%.
US Stock Market Move | YARTEMLEA drug receives FDA approval Omeros Corporation (OMER.US) surges by nearly 65%
US Stock Market Move | The US car safety regulatory agency has launched a defect investigation into the Model 3. Tesla, Inc. (TSLA.US) fell more than 1.4% in the short term.
RECOMMEND
